Kalaris Therapeutics, Inc. — SC 13G/A Filings
7 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Kalaris Therapeutics, Inc. (KLRS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Kalaris Therapeutics, Inc. has filed 7 SC 13G/A documents with the SEC since 2018. To view all SEC filings by Kalaris Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
POS AM
POSASR
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001193125-24-193035 | Aug 2, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-030301 | Feb 9, 2024 | — |
| SC 13G/A | — | 0000315066-24-000960 | Feb 9, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-002531 | Jan 9, 2024 | — |
| SC 13G/A | — | 0000315066-23-001423 | Feb 9, 2023 | — |
| SC 13G/A | — | 0000315066-22-000782 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000315066-21-000811 | Feb 8, 2021 | — |